{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T22:01:33Z","timestamp":1775253693893,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,1,20]],"date-time":"2015-01-20T00:00:00Z","timestamp":1421712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s00204-014-1419-z","type":"journal-article","created":{"date-parts":[[2015,1,19]],"date-time":"2015-01-19T09:10:52Z","timestamp":1421658652000},"page":"359-373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["5-, 12- and 15-Hydroxyeicosatetraenoic acids induce cellular hypertrophy in the human ventricular cardiomyocyte, RL-14 cell line, through MAPK- and NF-\u03baB-dependent mechanism"],"prefix":"10.1007","volume":"90","author":[{"given":"Zaid H.","family":"Maayah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman O. S.","family":"El-Kadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,20]]},"reference":[{"issue":"2","key":"1419_CR1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1073\/pnas.0811022106","volume":"106","author":"D Ai","year":"2009","unstructured":"Ai D, Pang W, Li N et al (2009) Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy. Proc Natl Acad Sci USA 106(2):564\u2013569. doi: 10.1073\/pnas.0811022106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"1419_CR2","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/01.RES.0000072977.86706.23","volume":"92","author":"H Akazawa","year":"2003","unstructured":"Akazawa H, Komuro I (2003) Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 92(10):1079\u20131088. doi: 10.1161\/01.RES.0000072977.86706.23","journal-title":"Circ Res"},{"issue":"8","key":"1419_CR3","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/bph.12066","volume":"168","author":"HN Althurwi","year":"2013","unstructured":"Althurwi HN, Tse MM, Abdelhamid G, Zordoky BN, Hammock BD, El-Kadi AO (2013) Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy. Br J Pharmacol 168(8):1794\u20131807. doi: 10.1111\/bph.12066","journal-title":"Br J Pharmacol"},{"issue":"9","key":"1419_CR4","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/nar\/19.9.2499","volume":"19","author":"NC Andrews","year":"1991","unstructured":"Andrews NC, Faller DV (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19(9):2499","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"1419_CR5","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.biocel.2008.02.020","volume":"40","author":"SP Barry","year":"2008","unstructured":"Barry SP, Davidson SM, Townsend PA (2008) Molecular regulation of cardiac hypertrophy. Int J Biochem Cell Biol 40(10):2023\u20132039. doi: 10.1016\/j.biocel.2008.02.020","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"1419_CR6","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ijc.25054","volume":"127","author":"N Bhattacharya","year":"2010","unstructured":"Bhattacharya N, Sarno A, Idler IS et al (2010) High-throughput detection of nuclear factor-kappaB activity using a sensitive oligo-based chemiluminescent enzyme-linked immunosorbent assay. Int J Cancer J Int du Cancer 127(2):404\u2013411. doi: 10.1002\/ijc.25054","journal-title":"Int J Cancer J Int du Cancer"},{"issue":"4","key":"1419_CR7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/01.RES.62.4.687","volume":"62","author":"KE Burhop","year":"1988","unstructured":"Burhop KE, Selig WM, Malik AB (1988) Monohydroxyeicosatetraenoic acids (5-HETE and 15-HETE) induce pulmonary vasoconstriction and edema. Circ Res 62(4):687\u2013698","journal-title":"Circ Res"},{"issue":"9","key":"1419_CR8","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1073\/pnas.78.9.5362","volume":"78","author":"J Capdevila","year":"1981","unstructured":"Capdevila J, Chacos N, Werringloer J, Prough RA, Estabrook RW (1981) Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid. Proc Natl Acad Sci USA 78(9):5362\u20135366","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"1419_CR9","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1172\/JCI5897","volume":"103","author":"T Cyrus","year":"1999","unstructured":"Cyrus T, Witztum JL, Rader DJ et al (1999) Disruption of the 12\/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Investig 103(11):1597\u20131604. doi: 10.1172\/JCI5897","journal-title":"J Clin Investig"},{"issue":"4","key":"1419_CR10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1124\/dmd.106.012823","volume":"35","author":"TC Delozier","year":"2007","unstructured":"Delozier TC, Kissling GE, Coulter SJ et al (2007) Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues. Drug Metab Dispos 35(4):682\u2013688. doi: 10.1124\/dmd.106.012823","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"1419_CR11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2174\/1389200211314060007","volume":"14","author":"OH Elshenawy","year":"2013","unstructured":"Elshenawy OH, Anwar-Mohamed A, El-Kadi AO (2013) 20-Hydroxyeicosatetraenoic acid is a potential therapeutic target in cardiovascular diseases. Curr Drug Metab 14(6):706\u2013719","journal-title":"Curr Drug Metab"},{"issue":"1","key":"1419_CR12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/hc0102.101365","volume":"105","author":"G Esposito","year":"2002","unstructured":"Esposito G, Rapacciuolo A, Naga Prasad SV et al (2002) Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation 105(1):85\u201392","journal-title":"Circulation"},{"issue":"3\u20134","key":"1419_CR13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.prostaglandins.2011.11.007","volume":"98","author":"C Fava","year":"2012","unstructured":"Fava C, Ricci M, Melander O, Minuz P (2012) Hypertension, cardiovascular risk and polymorphisms in genes controlling the cytochrome P450 pathway of arachidonic acid: a sex-specific relation? Prostaglandins Other Lipid Mediat 98(3\u20134):75\u201385. doi: 10.1016\/j.prostaglandins.2011.11.007","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"2","key":"1419_CR14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1161\/01.HYP.37.2.334","volume":"37","author":"D Gonzalez-Nunez","year":"2001","unstructured":"Gonzalez-Nunez D, Claria J, Rivera F, Poch E (2001) Increased levels of 12(S)-HETE in patients with essential hypertension. Hypertension 37(2):334\u2013338","journal-title":"Hypertension"},{"issue":"1","key":"1419_CR15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0008-6363(01)00433-3","volume":"53","author":"F Grabellus","year":"2002","unstructured":"Grabellus F, Levkau B, Sokoll A et al (2002) Reversible activation of nuclear factor-kappaB in human end-stage heart failure after left ventricular mechanical support. Cardiovasc Res 53(1):124\u2013130","journal-title":"Cardiovasc Res"},{"issue":"1","key":"1419_CR16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cardiores.2005.06.007","volume":"68","author":"GJ Gross","year":"2005","unstructured":"Gross GJ, Falck JR, Gross ER, Isbell M, Moore J, Nithipatikom K (2005) Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia\/reperfusion injury revisited. Cardiovasc Res 68(1):18\u201325. doi: 10.1016\/j.cardiores.2005.06.007","journal-title":"Cardiovasc Res"},{"issue":"1","key":"1419_CR17","doi-asserted-by":"crossref","first-page":"e85396","DOI":"10.1371\/journal.pone.0085396","volume":"9","author":"S Gu","year":"2014","unstructured":"Gu S, Zhang W, Chen J et al (2014) EPC-derived microvesicles protect cardiomyocytes from Ang II-induced hypertrophy and apoptosis. PLOS One 9(1):e85396. doi: 10.1371\/journal.pone.0085396","journal-title":"PLOS One"},{"issue":"4","key":"1419_CR18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/hc0402.102863","volume":"105","author":"S Hirotani","year":"2002","unstructured":"Hirotani S, Otsu K, Nishida K et al (2002) Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 105(4):509\u2013515","journal-title":"Circulation"},{"issue":"6","key":"1419_CR19","doi-asserted-by":"crossref","first-page":"478","DOI":"10.2133\/dmpk.20.478","volume":"20","author":"S Imaoka","year":"2005","unstructured":"Imaoka S, Hashizume T, Funae Y (2005) Localization of rat cytochrome P450 in various tissues and comparison of arachidonic acid metabolism by rat P450 with that by human P450 orthologs. Drug Metab Pharmacokinet 20(6):478\u2013484","journal-title":"Drug Metab Pharmacokinet"},{"issue":"2 Pt 2","key":"1419_CR20","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/hy0202.103788","volume":"39","author":"JD Imig","year":"2002","unstructured":"Imig JD, Zhao X, Capdevila JH, Morisseau C, Hammock BD (2002) Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension. Hypertension 39(2 Pt 2):690\u2013694","journal-title":"Hypertension"},{"issue":"2","key":"1419_CR21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/cvr\/cvn346","volume":"82","author":"CM Jenkins","year":"2009","unstructured":"Jenkins CM, Cedars A, Gross RW (2009) Eicosanoid signalling pathways in the heart. Cardiovasc Res 82(2):240\u2013249. doi: 10.1093\/cvr\/cvn346","journal-title":"Cardiovasc Res"},{"issue":"4","key":"1419_CR22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cardiores.2005.04.030","volume":"67","author":"S Kawano","year":"2005","unstructured":"Kawano S, Kubota T, Monden Y et al (2005) Blockade of NF-kappaB ameliorates myocardial hypertrophy in response to chronic infusion of angiotensin II. Cardiovasc Res 67(4):689\u2013698. doi: 10.1016\/j.cardiores.2005.04.030","journal-title":"Cardiovasc Res"},{"issue":"7","key":"1419_CR23","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.20082596","volume":"206","author":"Y Kayama","year":"2009","unstructured":"Kayama Y, Minamino T, Toko H et al (2009) Cardiac 12\/15 lipoxygenase-induced inflammation is involved in heart failure. J Exp Med 206(7):1565\u20131574. doi: 10.1084\/jem.20082596","journal-title":"J Exp Med"},{"issue":"1\u20133","key":"1419_CR24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tox.2004.04.011","volume":"201","author":"HM Korashy","year":"2004","unstructured":"Korashy HM, El-Kadi AO (2004) Differential effects of mercury, lead and copper on the constitutive and inducible expression of aryl hydrocarbon receptor (AHR)-regulated genes in cultured hepatoma Hepa 1c1c7 cells. Toxicology 201(1\u20133):153\u2013172. doi: 10.1016\/j.tox.2004.04.011","journal-title":"Toxicology"},{"issue":"12","key":"1419_CR25","doi-asserted-by":"crossref","first-page":"e29055","DOI":"10.1371\/journal.pone.0029055","volume":"6","author":"A Leychenko","year":"2011","unstructured":"Leychenko A, Konorev E, Jijiwa M, Matter ML (2011) Stretch-induced hypertrophy activates NFkB-mediated VEGF secretion in adult cardiomyocytes. PLoS One 6(12):e29055. doi: 10.1371\/journal.pone.0029055","journal-title":"PLoS One"},{"issue":"4","key":"1419_CR26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11033-007-9112-4","volume":"35","author":"S Li","year":"2008","unstructured":"Li S, Mingyan E, Yu B (2008) Adriamycin induces myocardium apoptosis through activation of nuclear factor kappaB in rat. Mol Biol Rep 35(4):489\u2013494. doi: 10.1007\/s11033-007-9112-4","journal-title":"Mol Biol Rep"},{"issue":"4","key":"1419_CR27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402\u2013408. doi: 10.1006\/meth.2001.1262","journal-title":"Methods"},{"issue":"5","key":"1419_CR28","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00204-012-0996-y","volume":"87","author":"ZH Maayah","year":"2013","unstructured":"Maayah ZH, El Gendy MA, El-Kadi AO, Korashy HM (2013) Sunitinib, a tyrosine kinase inhibitor, induces cytochrome P450 1A1 gene in human breast cancer MCF7 cells through ligand-independent aryl hydrocarbon receptor activation. Arch Toxicol 87(5):847\u2013856. doi: 10.1007\/s00204-012-0996-y","journal-title":"Arch Toxicol"},{"issue":"3","key":"1419_CR29","first-page":"725","volume":"88","author":"ZH Maayah","year":"2014","unstructured":"Maayah ZH, Ansari MA, El Gendy MA, Al-Arifi MN, Korashy HM (2014) Development of cardiac hypertrophy by sunitinib in vivo and in vitro rat cardiomyocytes is influenced by the aryl hydrocarbon receptor signaling pathway. Arch Toxicol 88(3):725\u2013738. doi: 10.1007\/s00204-013-1159-5","journal-title":"Arch Toxicol"},{"issue":"10","key":"1419_CR30","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1097\/HJH.0b013e328308de68","volume":"26","author":"PA Modesti","year":"2008","unstructured":"Modesti PA, Serneri GG, Gamberi T et al (2008) Impaired angiotensin II-extracellular signal-regulated kinase signaling in failing human ventricular myocytes. J Hypertens 26(10):2030\u20132039. doi: 10.1097\/HJH.0b013e328308de68","journal-title":"J Hypertens"},{"issue":"6 Pt 2","key":"1419_CR31","first-page":"H1774","volume":"259","author":"K Nozawa","year":"1990","unstructured":"Nozawa K, Tuck ML, Golub M, Eggena P, Nadler JL, Stern N (1990) Inhibition of lipoxygenase pathway reduces blood pressure in renovascular hypertensive rats. Am J Physiol 259(6 Pt 2):H1774\u2013H1780","journal-title":"Am J Physiol"},{"issue":"2","key":"1419_CR32","first-page":"153","volume":"22","author":"G Pearson","year":"2001","unstructured":"Pearson G, Robinson F, Beers Gibson T et al (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22(2):153\u2013183. doi: 10.1210\/edrv.22.2.0428","journal-title":"Endocr Rev"},{"issue":"4","key":"1419_CR33","doi-asserted-by":"crossref","first-page":"H1814","DOI":"10.1152\/ajpheart.2001.280.4.H1814","volume":"280","author":"PJ Reiser","year":"2001","unstructured":"Reiser PJ, Portman MA, Ning XH, Schomisch Moravec C (2001) Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles. Am J Physiol Heart Circ Physiol 280(4):H1814\u2013H1820","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"1419_CR34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00021.2001","volume":"82","author":"RJ Roman","year":"2002","unstructured":"Roman RJ (2002) P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82(1):131\u2013185. doi: 10.1152\/physrev.00021.2001","journal-title":"Physiol Rev"},{"issue":"4 Pt 1","key":"1419_CR35","first-page":"371","volume":"10","author":"M Sasaki","year":"1997","unstructured":"Sasaki M, Hori MT, Hino T, Golub MS, Tuck ML (1997) Elevated 12-lipoxygenase activity in the spontaneously hypertensive rat. Am J Hypertens 10(4 Pt 1):371\u2013378","journal-title":"Am J Hypertens"},{"issue":"4","key":"1419_CR36","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1159\/000189154","volume":"73","author":"ML Schwartzman","year":"1996","unstructured":"Schwartzman ML, da Silva JL, Lin F, Nishimura M, Abraham NG (1996) Cytochrome P450 4A expression and arachidonic acid omega-hydroxylation in the kidney of the spontaneously hypertensive rat. Nephron 73(4):652\u2013663","journal-title":"Nephron"},{"issue":"1","key":"1419_CR37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1385\/CBB:43:1:061","volume":"43","author":"S Sopontammarak","year":"2005","unstructured":"Sopontammarak S, Aliharoob A, Ocampo C, Arcilla RA, Gupta MP, Gupta M (2005) Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy. Cell Biochem Biophys 43(1):61\u201376. doi: 10.1385\/CBB:43:1:061","journal-title":"Cell Biochem Biophys"},{"issue":"48","key":"1419_CR38","doi-asserted-by":"crossref","first-page":"30580","DOI":"10.1016\/S0021-9258(18)43853-7","volume":"269","author":"J Thorburn","year":"1994","unstructured":"Thorburn J, McMahon M, Thorburn A (1994) Raf-1 kinase activity is necessary and sufficient for gene expression changes but not sufficient for cellular morphology changes associated with cardiac myocyte hypertrophy. J Biol Chem 269(48):30580\u201330586","journal-title":"J Biol Chem"},{"issue":"5\u20136","key":"1419_CR39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.vph.2013.02.004","volume":"58","author":"MM Tse","year":"2013","unstructured":"Tse MM, Aboutabl ME, Althurwi HN, Elshenawy OH, Abdelhamid G, El-Kadi AO (2013) Cytochrome P450 epoxygenase metabolite, 14,15-EET, protects against isoproterenol-induced cellular hypertrophy in H9c2 rat cell line. Vascul Pharmacol 58(5\u20136):363\u2013373. doi: 10.1016\/j.vph.2013.02.004","journal-title":"Vascul Pharmacol"},{"issue":"Suppl 3","key":"1419_CR40","doi-asserted-by":"crossref","first-page":"A114","DOI":"10.1136\/heartjnl-2014-306118.208","volume":"100","author":"A Vanezis","year":"2014","unstructured":"Vanezis A, Thaitirarot C, Butt M, Squire I, Samani N, Rodrigo G (2014) 208 The PKC epsilon\/AMPK ALPHA\/ENOS pathway is implicated as a mechanism by which remote ischaemic conditioning attenuates endothelin-1 mediated cardiomyocyte hypertrophy. Heart 100(Suppl 3):A114. doi: 10.1136\/heartjnl-2014-306118.208","journal-title":"Heart"},{"issue":"46","key":"1419_CR41","doi-asserted-by":"crossref","first-page":"29055","DOI":"10.1016\/S0021-9258(19)62012-0","volume":"269","author":"G Wallukat","year":"1994","unstructured":"Wallukat G, Morwinski R, Kuhn H (1994) Modulation of the beta-adrenergic response of cardiomyocytes by specific lipoxygenase products involves their incorporation into phosphatidylinositol and activation of protein kinase C. J Biol Chem 269(46):29055\u201329060","journal-title":"J Biol Chem"},{"issue":"1\u20134","key":"1419_CR42","first-page":"45","volume":"96","author":"CC Wu","year":"2011","unstructured":"Wu CC, Schwartzman ML (2011) The role of 20-HETE in androgen-mediated hypertension. Prostaglandins Other Lipid Mediat 96(1\u20134):45\u201353. doi: 10.1016\/j.prostaglandins.2011.06.006","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"49","key":"1419_CR43","doi-asserted-by":"crossref","first-page":"18733","DOI":"10.1073\/pnas.0609158103","volume":"103","author":"D Xu","year":"2006","unstructured":"Xu D, Li N, He Y et al (2006) Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci USA 103(49):18733\u201318738. doi: 10.1073\/pnas.0609158103","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\u20132","key":"1419_CR44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1474-8673.2009.00429.x","volume":"29","author":"MH Yousif","year":"2009","unstructured":"Yousif MH, Benter IF, Roman RJ (2009) Cytochrome P450 metabolites of arachidonic acid play a role in the enhanced cardiac dysfunction in diabetic rats following ischaemic reperfusion injury. Auton Autacoid Pharmacol 29(1\u20132):33\u201341. doi: 10.1111\/j.1474-8673.2009.00429.x","journal-title":"Auton Autacoid Pharmacol"},{"issue":"11","key":"1419_CR45","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.RES.87.11.992","volume":"87","author":"Z Yu","year":"2000","unstructured":"Yu Z, Xu F, Huse LM et al (2000) Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res 87(11):992\u2013998","journal-title":"Circ Res"},{"issue":"4","key":"1419_CR46","first-page":"173","volume":"8","author":"W Zhang","year":"2003","unstructured":"Zhang W, Elimban V, Nijjar MS, Gupta SK, Dhalla NS (2003) Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure. Exp Clin Cardiol 8(4):173\u2013183","journal-title":"Exp Clin Cardiol"},{"issue":"5","key":"1419_CR47","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/jcb.24445","volume":"114","author":"J Zong","year":"2013","unstructured":"Zong J, Zhang DP, Zhou H et al (2013) Baicalein protects against cardiac hypertrophy through blocking MEK-ERK1\/2 signaling. J Cell Biochem 114(5):1058\u20131065. doi: 10.1002\/jcb.24445","journal-title":"J Cell Biochem"},{"issue":"3","key":"1419_CR48","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.pharmthera.2009.12.002","volume":"125","author":"BN Zordoky","year":"2010","unstructured":"Zordoky BN, El-Kadi AO (2010) Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases. Pharmacol Ther 125(3):446\u2013463. doi: 10.1016\/j.pharmthera.2009.12.002","journal-title":"Pharmacol Ther"},{"issue":"11","key":"1419_CR49","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1124\/dmd.108.023077","volume":"36","author":"BN Zordoky","year":"2008","unstructured":"Zordoky BN, Aboutabl ME, El-Kadi AO (2008) Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats. Drug Metab Dispos 36(11):2277\u20132286. doi: 10.1124\/dmd.108.023077","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"1419_CR50","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.taap.2009.09.012","volume":"242","author":"BN Zordoky","year":"2010","unstructured":"Zordoky BN, Anwar-Mohamed A, Aboutabl ME, El-Kadi AO (2010) Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats. Toxicol Appl Pharmacol 242(1):38\u201346. doi: 10.1016\/j.taap.2009.09.012","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-014-1419-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-014-1419-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-014-1419-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T16:48:52Z","timestamp":1717692532000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-014-1419-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,20]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["1419"],"URL":"https:\/\/doi.org\/10.1007\/s00204-014-1419-z","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,20]]}}}